Comparison Phathom Pharmaceuticals (PHAT) with Competitors
Phathom Pharmaceuticals (PHAT) industry is Biotechnology.
Profit Margin
PHAT-52.09%
Industry-0.13%
Upside-51.96%
Operating Margin
PHAT-26.55%
Industry-2073.25%
Upside+2046.70%
Debt-to-Equity
PHAT-48.57%
Industry29.76%
Upside-78.33%
Free Cash Flow Yield
PHAT-11.46%
Industry-1.94%
Upside-9.52%
P/E
PHAT-4.92
Industry-18.88
Upside+1395.56%
P/S
PHAT3.73
Industry9.28
Upside-59.78%
P/B
PHAT25.37
Industry4.70
Upside+440.08%